Newron Pharmaceuticals S.p.A. (NP5.DE)

EUR 8.8

(-0.34%)

Operating Expenses Summary of Newron Pharmaceuticals S.p.A.

  • Newron Pharmaceuticals S.p.A.'s latest annual operating expenses in 2023 was 21.41 Million EUR , up 10.42% from previous year.
  • Newron Pharmaceuticals S.p.A.'s latest quarterly operating expenses in 2024 Q2 was 11.09 Million EUR , down 0.0% from previous quarter.
  • Newron Pharmaceuticals S.p.A. reported a annual operating expenses of 19.39 Million EUR in annual operating expenses 2022, up 7.05% from previous year.
  • Newron Pharmaceuticals S.p.A. reported a annual operating expenses of 18.11 Million EUR in annual operating expenses 2021, down -21.32% from previous year.
  • Newron Pharmaceuticals S.p.A. reported a quarterly operating expenses of 9.78 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Newron Pharmaceuticals S.p.A. reported a quarterly operating expenses of 10.88 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Newron Pharmaceuticals S.p.A. (2023 - 2005)

Historical Annual Operating Expenses of Newron Pharmaceuticals S.p.A. (2023 - 2005)

Year Operating Expenses Operating Expenses Growth
2023 21.41 Million EUR 10.42%
2022 19.39 Million EUR 7.05%
2021 18.11 Million EUR -21.32%
2020 23.02 Million EUR -13.14%
2019 26.51 Million EUR 50.37%
2018 17.63 Million EUR -0.8%
2017 17.77 Million EUR -19.4%
2016 22.05 Million EUR -17.66%
2015 26.78 Million EUR 109.68%
2014 12.77 Million EUR 12.88%
2013 11.31 Million EUR -2.63%
2012 11.62 Million EUR 71.86%
2011 6.76 Million EUR -69.87%
2010 22.44 Million EUR -17.17%
2009 27.09 Million EUR 21.78%
2008 22.25 Million EUR 25.19%
2007 17.77 Million EUR -0.94%
2006 17.94 Million EUR 19.02%
2005 15.07 Million EUR 0.0%

Peer Operating Expenses Comparison of Newron Pharmaceuticals S.p.A.

Name Operating Expenses Operating Expenses Difference
Redcare Pharmacy NV 399.83 Million EUR 94.644%